Company Name
Wuhan RS Pharmaceuticals Co., Ltd.
Year of Establishment
2010
Enterprise Size
200 to 249
Annual Turnover(USD)
choose not to disclose
Company Introduction
QR Science & Technology Development Co., Ltd has carved a niche for itself in the Chinese pharmaceutical industry, built trust among customers and business partners by its high quality products and service, and taken responsibility for the utmost care of patients, clients, and the well-being of the society.
We are a leading developer, manufacturer and trusted supplier of finished dosage forms (FDFs -Wuhan QR Pharmaceuticals Co., Ltd) and Active Pharmaceutical Ingredients (APIs - Wuhan ZY Pharmaceutical Co., Ltd). QR is dedicated in drug research and development in the fields of liver disease, cardiovascular, digesion, anti-fungal,and respiratory diseases.
Main Competitive Advantages
Experienced R&D Staff,Contract Manufacturing,Quality Service,
Milestone
2010.01, Established.
2013.12, Got CFDA GMP of Atorvastatin Calcium & Fasudil Mesylate.
2016.09, Got CFDA GMP of Sofalcone